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Plakoglobin as a Regulator of Desmocollin
Gene Expression
Etienne Tokonzaba1, Jiangli Chen1, Xing Cheng2, Zhining Den2, Radhika Ganeshan1,
Eliane J. Mu+ller3 and Peter J. Koch1,2,4
Desmosomes are cell adhesion junctions required for the normal development and maintenance of mammalian
tissues and organs such as the skin, skin appendages, and the heart. The goal of this study was to investigate how
desmocollins (DSCs), transmembrane components of desmosomes, are regulated at the transcriptional level.
We hypothesized that differential expression of the Dsc2 and Dsc3 genes is a prerequisite for normal
development of skin appendages. We demonstrate that plakoglobin (Pg) in conjunction with lymphoid
enhancer-binding factor 1 (Lef-1) differentially regulates the proximal promoters of these two genes. Specifically,
we found that Lef-1 acts as a switch activating Dsc2 and repressing Dsc3 in the presence of Pg. Interestingly, we
also determined that NF-kB pathway components, the downstream effectors of the ectodysplasin-A (EDA)/
ectodysplasin-A receptor (EDAR)/NF-kB signaling cascade, can activate Dsc2 expression. We hypothesize that Lef-
1 and EDA/EDAR/NF-kB signaling contribute to a shift in Dsc isoform expression from Dsc3 to Dsc2 in placode
keratinocytes. It is tempting to speculate that this shift is required for the invasive growth of placode
keratinocytes into the dermis, a crucial step in skin appendage formation.
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INTRODUCTION
Desmosomes are cell adhesion complexes that are assembled
at the plasma membrane where they serve as membrane
anchors for intermediate filament proteins (Cheng and
Koch, 2004; Cheng et al., 2005; Dubash and Green, 2011).
The importance of this cell junction for organ stability and
function is demonstrated by the severe acquired and inherited
diseases of the skin, skin appendages (e.g., hair), and the heart
that result from impaired desmosome function (see, e.g.,
Amagai and Stanley, 2012; Petrof et al., 2012; Swope et al.,
2013). These observations in human patients are further
supported by the severe skin and heart phenotypes of mice
with mutations in genes encoding desmosomal components
(see, e.g., Koch et al., 1997, 1998; Chen et al., 2008;
Ganeshan et al., 2010; Li et al., 2011, 2012). Desmosomes
also contribute to cell sorting, morphogenetic cell movement,
and the formation of the proper histoarchitecture during
embryonic development (Cheng and Koch, 2004).
Desmosomes contain transmembrane adhesion molecules
(desmosomal cadherins, desmogleins (DSGs) and desmocol-
lins (DSCs)) and associated plaque proteins (reviewed in
Cheng et al., 2005; Dubash and Green, 2011). The main
plaque proteins belong either to the armadillo family of
structural and signaling proteins (plakoglobin (Pg) and
plakophilins) or the plakin family (desmoplakin). The mouse
genome encodes three Dsc and six Dsg genes. All DSG and
DSC proteins are synthesized in the epidermis of the skin
and in skin appendages: e.g., Dsc2 and Dsc3 are present in
the basal and immediate suprabasal layers, whereas Dsc1 is
mainly restricted to the granular layer of the mouse
epidermis (references in Chen et al., 2008). It is thought
that the specific complement of DSG and DSC proteins
affects the adhesive and potentially the signaling properties
of desmosomes (see, e.g., Schmidt and Koch, 2007; Muller
et al., 2008). However, little is known about the gene-
regulatory mechanisms that control the expression of these
desmosomal genes (see, e.g., Oshiro et al., 2003; Smith et al.,
2004; Oshiro et al., 2005). In this study, we focused on the
regulation of the Dsc2 and Dsc3 genes; their coexpression in
the deep layers of the mouse epidermis suggests that they may
have a role in keratinocyte differentiation and skin appendage
formation (see, e.g., Chidgey et al., 1997; Cheng and Koch,
2004). Furthermore, we questioned whether signaling
cascades known to have important roles during skin
appendage formation affect the expression of Dsc2 and
Dsc3, respectively.
Both the WNT and the ectodysplasin-A (EDA)/ ectodyspla-
sin-A receptor (EDAR)/NF-kB pathways have been shown
to have critical roles in hair follicle (HF) formation
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(Schmidt-Ullrich et al., 2001; Zhang et al., 2009). The canonical
Wnt cascade ultimately affects target gene expression via
b-catenin/T-cell factor (TCF)/lymphoid enhancer-binding
factor (Lef) complexes. Pg, which is sequence related to
b-catenin, has also been shown to act as a transcription
factor, both in conjunction and independent of TCF/Lef factors
(see e.g., Simcha et al., 1998; Zhurinsky et al., 2000; Shtutman
et al., 2002; Maeda et al., 2004; Teuliere et al., 2004;
Williamson et al., 2006; Galichet et al., 2012). Similar to
b-catenin, Pg does not possess a DNA-binding domain, i.e., it
requires cofactors (such as TCF/Lef factors) to bind to promoter
sequences.
It is well established that Pg, independent of b-catenin
signaling, is a key regulator of various cellular pro-
cesses such as migration (Rieger-Christ et al., 2005; Yin
et al., 2005; Franzen et al., 2012), proliferation (Li et al.,
2012), apoptosis (Dusek et al., 2007), and gene expression
(see above).
Here we demonstrate that Pg, in conjunction with Lef-1,
can control Dsc2 and Dsc3 gene expression: in the presence
of Lef-1, Pg activates Dsc2 and represses Dsc3 expression.
Furthermore, we show that NF-kB proteins, the downstream
effectors of EDA/EDAR signaling (Schmidt-Ullrich et al.,
2001), activate Dsc2 as well. Both the EDA/EDAR/NF-kB
and the TCF/Lef signaling have crucial roles in the early steps
of HF formation. Our results predict that these two pathways
shift expression from Dsc3 to Dsc2 in placode keratinocytes
invading the dermis, a process that might be required
for effective keratinocyte migration and thus appendage
formation. To the best of our knowledge, these results
provide previously unreported evidence that the catenin/
TCF/Lef and NF-kB signaling cascades control Dsc gene
expression in keratinocytes.
RESULTS
Dsc gene regulation in skin appendage formation
It is thought that changing the molecular composition of
desmosomes is one mechanism used by keratinocytes to
adapt their cell adhesion system to their specific environment.
For example, in the early stages of skin appendage formation,
desmocollins are downregulated in placode keratinocytes
invading the dermis (Nanba et al., 2000, 2001). However,
little is known regarding gene-regulatory mechanisms
that control Dsc gene expression in skin. To begin to
identify gene-regulatory pathways controlling Dsc gene
expression, we cloned and sequenced the proximal
promoters of mouse, Dsc2 and Dsc3. These two Dsc genes
are expressed in the basal layers of the interfollicular
epidermis, the cellular compartment that maintains the
epidermis and that forms HFs.
DNA sequence analysis revealed the presence of putative
TCF/Lef (Figure 1a and b) and NF-kB (see below) target sites in
the Dsc2 and Dsc3 promoters. Considering that the Wnt
pathway, which affects gene expression via catenin/TCF/Lef
transcription factors, and the NF-kB pathways have been
shown to have major roles in HF formation, we decided to
focus on the role of these two signaling cascades in Dsc gene
regulation.
TCF/Lef regulation of the Dsc2 and Dsc3 promoters
We cloned 2 kb of the genomic DNA sequences immediately
upstream of the Dsc2 and Dsc3 translation start codons
(Figure 1a and b). These DNA fragments were cloned into a
promoter-less Luciferase reporter vector designed to assess
transcriptional activity of promoter fragments (reporter assays).
Both the Dsc2 and Dsc3 constructs showed reporter activity in
primary mouse keratinocytes (data not shown). Next, we
introduced point mutations abrogating DNA binding of
TCF/Lef factors to their target sites into both promoters
(Figure 1a and b). The wild-type, but not the mutant TCF/Lef
sites, showed binding of Lef-1 and TCF-4 as demonstrated by
chromatin immunoprecipitation (ChIP) assays (Figure 1c and
d). TCF3 behaved identical to TCF-4 in all assays performed in
this study. Consequently, only the Lef-1 and TCF-4 data are
shown. All ChIP assays and biochemical experiments were
conducted in canine MDCK (Madin Darby canine kidney)
cells, whereas reporter assays and gene expression studies
were conducted in primary mouse keratinocytes. MDCK cells
express Dsc2 and Dsc3 (data not shown). Owing to
differences in the promoter DNA sequences of dog and
mouse and the use of species-specific antibodies, we were
able to investigate protein–DNA and protein–protein interac-
tions in MDCK cells without the interference of endogenous
canine genes and proteins.
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Figure 1. Identification and functional characterization of T-cell factor/
lymphoid enhancer-binding factor (TCF/Lef)–binding sites in the desmocollin
2 (Dsc2) and desmocollin 3 (Dsc3) promoters. (a, b) Schematic representation
of putative transcription factor–binding sites (TCF/Lef) in the proximal Dsc
promoters. The arrows indicate translation start sites (ATG; A is defined as
position þ1). The DNA sequences of wild-type (Wt) and mutant (Mut)
transcription factor–binding sites are shown. (c, d) Chromatin
immunoprecipitation (ChIP) assays demonstrating TCF/Lef binding to the
predicted target sites in the Dsc promoters. Note that the point mutations
introduced into the TCF/Lef target sequences (Dsc2 Mut, Dsc3 Mut) abrogate
binding of the transcription factors. Input, chromatin used for
immunoprecipitation; IgG, immunoprecipitation (IP) with unspecific IgG.
(e, f) Reporter assays in mouse keratinocytes. Note that inactivation of the
TCF/Lef-binding sites in the Dsc3 construct increases reporter activity
significantly. Error bars, SD. Star indicates a statistically significant result
(Po0.05).
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Next, we assessed whether loss of functional TCF/Lef sites
affected reporter activity in primary keratinocytes. As shown in
Figure 1, Dsc2 promoter activity was unchanged when
wild-type and mutant reporter constructs lacking a functional
TCF/Lef site were compared (Figure 1e). Dsc3 promoter
activity was significantly increased in the mutant construct,
indicating that this site is repressive (Figure 1f).
b-Catenin expression has no effect on the proximal Dsc2 and
Dsc3 promoters
TCF/Lef sites are the primary target sites of b-catenin/TCF/Lef
transcription factor complexes, the principal effectors of
the Wnt signaling pathway. ChIP assays demonstrated that
b-catenin can bind to the Dsc3 but not the Dsc2 promoter
(Supplementary Figure S1 online; these experiments were
conducted in MDCK cells expressing TCF-4 as a cofactor,
data not shown). To determine whether b-catenin can influ-
ence Dsc promoter activity, we transfected the Dsc reporter
constructs with different combinations of TCF/Lef factors into
keratinocytes. We did not observe a statistically significant
effect of these b-catenin/TCF/Lef factors on Dsc2 or Dsc3
reporter activity (Supplementary Figure S1 online). A slight
repression of Dsc3 reporter activity by b-catenin and Lef-1 was
often observed but did not reach statistical significance.
Pg is a key regulator of Dsc2 and Dsc3 promoter activity
Pg has been shown to regulate gene expression in keratino-
cytes and other epithelial cell types (see references in the
Introduction section). To determine whether Pg can affect Dsc
promoter activity, we first assessed the ability of this protein to
bind the Dsc2 and Dsc3 promoter fragments. As shown in
Figure 2a and b, Pg binds to the Dsc2 promoter but not the
Dsc3 promoter in the presence of Lef-1. Reporter assays
demonstrated that Pg can affect both promoters, although its
effects are dependent on Lef-1 (Figure 2c and d); in the
presence of Lef-1, Pg activates the Dsc2 promoter, whereas
Dsc3 promoter activation occurs in the absence of ectopic
TCF/Lef expression. These results suggest that Lef-1 can act as
a switch that shifts activity from the Dsc3 to the Dsc2
promoter in the presence of Pg.
Neither Lef-1, TCF-3, nor TCF-4 had any effect on the Dsc2
or Dsc3 promoter in single transfection experiments (data not
shown). These results are expected given that keratinocytes
express endogenous TCF/Lef factors, but show very low
cytoplasmic and nuclear Pg levels (Williamson et al., 2006),
conditions that favor low Dsc2 and Dsc3 reporter activity.
As shown in Figure 2e, Dsc2 promoter activation by Pg and
Lef-1 was dependent on the presence of a functional TCF/Lef-
binding site. In the case of the Dsc3 promoter, we found no
additive or synergistic effects of Pg and the TCF/Lef mutation
(Figure 2f). These findings are consistent with the hypothesis that
Pg asserts its activating effect on Dsc2 by binding to the TCF/Lef
site, whereas this was not the case for the Dsc3 promoter.
We next assessed the effects of Pg and Lef-1 coexpression
on the endogenous Dsc2 and Dsc3 gene activity in primary
keratinocytes by quantitative reverse transcriptase–PCR. As
shown in Figure 2g and h, both genes responded to ectopic
Pg/Lef expression as predicted by our reporter assays,
confirming the validity of our conclusions for the regulation
of these genes in keratinocytes.
To gain further insights into the mechanisms by which Pg
and Lef-1 control Dsc gene expression, we assessed whether
Pg can bind to Lef-1. As shown in Figure 3a, Lef-1 and Pg
can form a complex as shown by coimmunoprecipitation
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Figure 2. Effects of plakoglobin (Pg) on desmocollin (Dsc) reporter activities.
(a, b) Chromatin immunoprecipitation (ChIP) assays demonstrating direct
binding of Pg to the Dsc2 promoter in the presence of lymphoid enhancer-
binding factor 1 (Lef-1). Note that Pg does not bind the Dsc3 promoter in the
presence of Lef-1 (b) or T-cell factor 4 (TCF-4; data not shown). Input,
chromatin used for immunoprecipitation (IP); IgG, IP with unspecific IgG.
(c–f) Reporter assays in keratinocytes. (c) Coexpression of Pg and Lef-1
markedly increases Dsc2 reporter activity, whereas all other combinations of
Pg and TCF/Lef factors have no effect. (d) The Dsc3 promoter is activated in the
presence of Pg. This activation is reversed in cells coexpressing Pg and
TCF-4 or Lef-1. (e) Dsc2 promoter activation by Pg and Lef-1 is dependent
on the presence of a functional TCF/Lef-binding site. Mut, mutant. (f) Pg
overexpression and loss of a functional TCF/Lef–binding site increase Dsc3
reporter activity to a similar extent. Note that expression is normalized to the
baseline expression of the WT promoter (set to 1). (g, h) Endogenous Dsc gene
expression in keratinocytes transfected with different combinations of Pg and
TCF/Lef factors. Error bars, SD. Stars indicate statistically significant results
(Po0.05).
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experiments using Lef-1 antibodies. Most interestingly, ChIP
competition experiments suggested that the interaction of Pg
and Lef-1 interferes with the ability of Lef-1 to bind to the
Dsc3 promoter (Figure 3b). Considering that TCF/Lef-1 com-
plexes can act as transcriptional repressors (see, e.g., Hoverter
and Waterman, 2008), these results raise the possibility that Pg
could activate Dsc3 expression by interfering with the binding
of a TCF/Lef repressor complex to the Dsc3 promoter. Further
support for this hypothesis is provided by western blot
experiments (Figure 3c and d), demonstrating that ectopically
expressed Pg can interfere with the nuclear accumulation of
Lef-1 and thus potentially suppress the formation of a repressor
complex at the Dsc3 promoter. On the other hand, Lef-1 is
required to shuttle Pg into the cell nucleus, where it activates
the Dsc2 promoter as shown in Figure 3d and e. The data
summarized above demonstrate that Lef-1 and Pg localize
to the nucleus, which is predicted to lead to an activation of
the Dsc2 gene and a suppression of the Dsc3 gene.
Topology of Lef-1 and Dsc3 expression in developing hair
follicles is mutually exclusive
Our results so far suggest that Lef-1 can act as a switch
between Dsc2 and Dsc3 expression and that the presence of
Lef-1 in keratinocytes can suppress the Dsc3 gene. We
therefore compared the distribution of DSC3 and Lef-1 in
transgenic mice expressing a nuclear LacZ reporter under
the control of the Dsc3 promoter (Dsc3-LacZ mice). These
animals were designed to identify cells and tissues that express
low levels of Dsc3, or cells in which antigen masking
prevented protein detection via antibodies. In all develop-
mental stages and tissues examined so far, DSC3 antibody
staining and LacZ transgene activity perfectly overlapped
(data not shown).
We conducted whole-mount b-galactosidase staining
experiments using Dsc3-LacZ embryos (Figure 4a). At embryo-
nic day 15.5 (E15.5), b-galactosidase activity was prominent
in whisker pads (vibrissae follicles), in mammary gland buds,
and in developing HFs over the entire body surface (Figure 4a,
and data not shown). Strikingly, the overall DSC3-LacZ
expression pattern appeared similar to the staining patterns
observed in transgenic embryos of the same age that expressed
a TCF/Lef-regulated promoter driving a LacZ reporter
(Figure 4b; Bat-Gal; Maretto et al., 2003). However, a
histochemical analysis revealed that the expression patterns
of the Wnt pathway components (Lef-1; TCF-3/-4; data not
shown) and the DSC3-LacZ transgene did not overlap at the
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Figure 3. Plakoglobin (Pg) colocalizes in the nucleus with lymphoid enhancer-binding factor 1 (Lef-1) and disrupts T-cell factor (TCF)/Lef transcription factor
binding to the desmocollin 3 (Dsc3) promoter. (a) Co-immunoprecipitation (Co-IP) assays demonstrating an interaction between Pg and Lef-1. (b) Chromatin
immunoprecipitation (ChIP) assays demonstrating that increasing amounts of Pg (measured in mg plasmid transfected) interfere with the binding of Lef-1 to the Dsc3
promoter. Input, chromatin used for immunoprecipitation; IgG, IP with unspecific IgG. (c, d) Western blot analysis of Madin Darby canine kidney (MDCK) cells
transfected with Pg and Lef-1 (transfection constructs shown on top; NT, not transfected). The nuclear (N) and cytoplasmic (C) distribution of the proteins is shown.
Antibodies used to detect Lef-1 and the KT3-tagged plakoglobin construct are shown on the left sides of the blots. Our Lef-1 antibody does not detect endogenous
Lef-1 expression in MDCK cells. Lamin B1 (nuclear fraction) and a-tubulin (cytoplasmic fraction) antibodies were used as controls. (e) Immunofluorescence
microscopy of MDCK cells transfected with Pg and Lef-1. The antibodies used for staining are indicated. Note the nuclear colocalization of Pg and Lef-1 in several
cells (arrows). Bar¼ 50mm.
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cellular level. In fact, Wnt activity (Lef-1 expression) and
Dsc3 expression were mutually exclusive (Figure 4c and d).
We observed that LacZ-positive (Dsc3-expressing) cells were
found in the suprabasal layer on top of the newly forming HFs.
Lef-1, on the other hand, was observed in the leading edge of
keratinocytes growing down into the dermis and throughout
the basal cell layer. These findings were confirmed by staining
E16.5 wild-type mouse epidermis with Lef-1 and DSC3
antibodies (Figure 4e–h). Strong Lef-1 antibody staining
correlated with reduced or absent staining for DSC3. Unfortu-
nately, we were not able to assess the distributions of DSC2, as
antibodies that recognize mouse DSC2 are not available. Pg
antibodies stained cell–cell borders in placode keratinocytes
(data not shown). Nuclear Pg staining was not observed,
possibly because of epitope masking or low nuclear Pg levels.
NF-jB regulation of the Dsc2 gene
Our initial analysis of the Dsc promoters indicated the
presence of putative NF-kB (Rel)-binding sites in both Dsc
promoters. We thus performed ChIP assays and reporter
assays to determine the effect of Rel factors and a dominant-
negative (DN) construct blocking NF-kB signaling (IkB-DN)
on Dsc promoter activity. The results shown in Figure 5a–c
demonstrate that c-Rel specifically binds to and activates the
proximal Dsc2 promoter, whereas we did not observe any
effect of the NF-kB factors on the proximal Dsc3 promoter
(Figure 5d). We then transfected primary keratinocytes
with the NF-kB factors and assessed endogenous Dsc gene
expression (Figure 5e and f). We confirmed the specific
activation of the endogenous Dsc2 gene by ectopic expression
of c-Rel.
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Dsc3-LacZ BAC
Dsc3Lef-1
Dsc3Lef-1
Dsc3Lef-1
β-Gal
β-Gal Ab Lef-1 Ab
β-GalBAT-gal
Figure 4. Wnt activity and desmocollin 3 (Dsc3) expression during mouse appendage development. (a) Whole-mount in situ staining for b-galactosidase (b-gal)
activity of a transgenic mouse (Dsc3-LacZ BAC, embryonic day 15.5 (E15.5)) expressing b-gal under the control of the Dsc3 promoter. Note that whisker pads, hair
follicles, and mammary glands (not shown) are strongly stained. (b) Whole-mount b-gal staining of a BAT-gal transgenic mouse (Maretto et al., 2003) at E15.5.
Note the similar staining patterns of the transgenic mice shown in (a) and (b). (c) Immunohistochemical staining of a skin section from a Dsc3-LacZ BAC mouse at
E15.5 with (c) b-gal antibodies (Abs) and (d) Lef-1 Abs. The LacZ transgene contains a nuclear localization signal. Note that b-gal and Lef-1 expression appears to
be mutually exclusive. Arrows point to Lef-1-expressing cells in a placode and a dermal papilla of a forming hair follicle. (e, g) Immunofluorescence staining of a
developing hair follicle in wild-type mouse skin at E16.5 with antibodies against Lef-1 and DSC3. The area demarcated by the dotted box is shown at higher
magnification in (h). (h) The large arrow points to DSC3-positive keratinocytes in the basal cell layer. The short arrow points to DSC3-negative and Lef-1-positive
cells in a forming hair placode. Dotted lines in e and h indicate basement membrane area. Bar¼ 50mm.
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DISCUSSION
It has been shown that deregulated expression or loss of
desmosomal cadherins, including Dsc, can lead to abnormal
differentiation of the epidermis and defects in HFs (see,
e.g., Chidgey et al., 2001; Elias et al., 2001; Merritt et al.,
2002; Hardman et al., 2005), suggesting that tight control of
Dsc gene expression is required for normal epidermal
development and homeostasis. In this study, we focused on
the regulation of Dsc2 and Dsc3, the two DSCs expressed in
the deep epidermis, the compartment that maintains the skin
and which has a crucial role in skin appendage development.
Little is known regarding gene-regulatory pathways that
control the expression of Dsc genes in processes such as
epidermal differentiation and HF formation. Epidermal appen-
dage formation requires extensive remodeling of cell adhesion
systems, including desmosomes (Kurzen et al., 1998). The first
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NF-kB activity. The promoter activities in the absence of ectopically expressed transcription factors are defined as relative expression level 1. (d) The Dsc3 reporter
construct does not show any significant changes in activity in response to NF-kB transcription factors. (e, f) Endogenous Dsc gene expression in mouse
keratinocytes. (e) c-Rel ectopic expression significantly increases endogenous Dsc2 expression. (f) None of the NF-kB transcription factors affects endogenous Dsc3
expression. (g) Simplified model of signaling pathways active in hair follicle placodes and their proposed effects on Dsc2 and Dsc3 gene expression. Note that
open arrows symbolize the upregulation and downregulation of gene expression, respectively. Error bars, SD. Stars indicate statistically significant results
(Po0.05). Lef-1, lymphoid enhancer-binding factor 1; Tcf, T-cell factor.
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step in the development of these appendages is placode
formation. Keratinocytes in these structures segregate from
the surrounding epidermis and then begin to invade the
dermis. Nanba et al. (2000, 2001) have demonstrated that
DSCs are downregulated both in the hair and mammary
gland placodes. However, the antigen specificity of the
antibody used by these authors was not determined, i.e., it
was not known which of the DSC proteins was actually
downregulated. Given the results presented in this study, it is
likely that the main desmosomal cadherin isoform
downregulated in this process is Dsc3.
The expression of classical cadherins is also switched during
hair follicle formation. E-cadherin is downregulated in HF
placodes, whereas P-cadherin is upregulated. Furthermore, it
was shown that forced expression of E-cadherin inhibits HF
formation (Jamora et al., 2003), demonstrating that control of
cadherin isoform expression is crucial for HF formation.
Given our results, it is tempting to speculate that an
analogous switch occurs from Dsc3 (TCF/Lef factor-mediated
repression) to Dsc2 (Pg/Lef-1-mediated induction) in placode
keratinocytes (Figure 5g). Unfortunately, owing to a lack of
appropriate antibodies, we currently do not have the tools
required to assess DSC2 expression in mouse epidermis.
Nevertheless, expression studies in human embryonic epider-
mis indicated increased DSC2 and reduced DSC3 expression
in bulbous hair pegs, suggesting that the above postulated
switch from Dsc3 to Dsc2 expression is likely to occur in
mammalian skin (Kurzen et al., 1998).
Pg appears to activate both the Dsc2 and the Dsc3
promoter. Previous studies have suggested that Pg can signal
by changing the levels of signaling active b-catenin in cells.
Our experiments failed to demonstrate a role of b-catenin in
regulating the two Dsc genes, suggesting that the signaling we
observed is a specific function of Pg.
The Dsc2 promoter requires Lef-1 for activation and this
regulation is dependent on the TCF/Lef-binding site in the
Dsc2 promoter. Interestingly, this effect is specific for Lef-1 as
TCF3 and TCF4 do not appear to be able to substitute for
Lef-1. It is noteworthy that Lef-1 expression facilitates nuclear
accumulation of Pg, a prerequisite for activation of the
Dsc2 gene.
Pg activated the Dsc3 promoter without direct binding.
Interestingly, ectopic expression of TCF/Lef factors completely
blocked Pg-mediated activation of the Dsc3 promoter. This
suggests that Pg interferes with the activity of a repressor
complex containing TCF/Lef factors that inhibits the Dsc3
promoter. A likely mechanism that could explain this observa-
tion is that binding of Pg to TCF/Lef proteins causes a
depletion of the TCF/Lef pool, thus preventing these factors
from forming an inhibitory complex on the Dsc3 promoter.
Previous experiments in mouse models suggested that Pg is
not required for the formation of HFs (Teuliere et al., 2004; Li
et al., 2012). These results suggest the existence of alternative
mechanisms that can regulate a switch of Dsc isoforms,
specifically the activation of Dsc2. NF-kB signaling might be
such an alternative mechanism. Our experiments revealed a
role of c-Rel, a NF-kB protein, in activating the Dsc2 gene.
NF-kB proteins are downstream effectors of the EDA/EDAR/
NF-kB pathway, which interact with the Wnt pathway, a
process crucial for HF formation during embryogenesis (Zhang
et al., 2009). The observation that both catenin/TCF/Lef and
NF-kB signaling are required for pelage hair development, and
our in vitro data demonstrating differential regulation of Dsc
genes by these two pathways, suggest the possibility that both
signaling cascades partially function through modulating
desmosomal cell adhesion.
On the basis of the observation summarized above, we
suggest the following mechanisms for the regulation of Dsc2
and Dsc3 gene expression during the early stages of skin
appendage formation: Wnt activation in the early placode
leads to an increase accumulation of Lef-1 in placodes. Lef-1,
potentially in conjunction with other corepressors (Hoverter
and Waterman, 2008; Arce et al., 2009), binds to the Dsc3
promoter and inhibits expression, thus leading to a reduction
in the desmosomal adhesion receptors present at the plasma
membrane. In turn, this could lead to a transient increase
of cytoplasmic Pg, which is usually bound to the carboxy-
terminal domain of DSC3. Given the abundance of Lef-1 in
placode keratinocytes, Pg would then form a transcription
complex with Lef-1 and activate the Dsc2 promoter. This
chain of events would lead to a shift from DSC3 to DSC2 as
the main DSC synthesized in placode keratinocytes, which
would be consistent with the proposed distribution of these
two proteins in skin placodes (our data and Kurzen et al.,
1998). Activation of the EDA/EDAR pathway, via its NF-kB
effectors, would then further facilitate the shift from DSC3 to
DSC2. It is possible that this change from DSC3 to DSC2 is
better suited to support invasive keratinocytes growth. In this
context, it is noteworthy that we have previously shown in
a mouse model that invasive growth of skin squamous
cell carcinoma is associated with a specific loss of Dsc3
expression in tumor cells (Chen et al., 2011). Similar results
have also been reported in other types of cancer, such as
breast cancer (Klus et al., 2001).
Further experiments will be required to unequivocally prove
this model. It is tempting to speculate that changes in
desmosomal cell adhesion might affect the signaling pool
of plakoglobin and thus, in a feedback loop, control the
expression of genes that encode central desmosomal compo-
nents. This represents a previously unreported and exciting
concept that can now be tested in vivo.
MATERIALS AND METHODS
Animal protocols
Animal experiments were approved by the institutional animal
care and use committee of the University of Colorado Denver
(UC Denver; Denver, CO).
Generation of Dsc promoter constructs and luciferase reporter
assays
A total of 2 kb promoter sequences immediately upstream of the Dsc2
and Dsc3 translation start codons were cloned into pGL3-basic vector
(Promega, Madison, WI), which contains a promoter-less luciferase
reporter cassette. TCF/Lef-1 mutations were generated by PCR using
primers DSC2-5F/5R and DSC3-2F/2R (Supplementary Table S1
online). The following expression vectors were used: CMV-bgal
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(Dennis Roop, UC Denver); pcDNA1.1p65 and pcDNA-Ikb-DN
(Rune Toftga˚rd, Karolinska Institute, Sweden); pcmv4c-Rel (Warner
Greene, University of California, San Francisco, San Francisco, CA)
(Doerre et al., 1993); pCS2 DNPb-catenin (Pamela Cowin, New York
University, New York, NY) (Imbert et al., 2001); pRcCMV
plakoglobin expression vector tagged with a KT3 epitope (Ansgar
Smith, University of Marburg, Marburg, Germany); pCS2-hLef-1 (Rolf
Kemler, Max-Planck Institute, Freiburg, Germany) (Huber et al.,
1996); and pGLOWMYC-hTcf-4 (Hans Clevers, University Hospital,
Utrecht, The Netherlands) (Korinek et al., 1997). Plasmids were
transiently transfected into the canine kidney epithelial cell line
MDCK (ATCC CCL-34) and mouse keratinocytes (MPEK-BL6;
Cellntec, Bern, Switzerland), using the Nucleofector Technology
(Lonza, Walkersville, MD). Reporter activities were measured with
the ‘‘Chemiluminescent Reporter Gene Assay System’’ (Applied
Biosystems, Bedford, MA) using a Glomax Multi Detection System
(Promega, Madison, WI). The results shown represent average
expression levels from three independent experiments, each
conducted in triplicate (error bars in all figures: SD, P-values of
o0.05 were considered statistically significant).
ChIP experiments
ChIP assays were performed essentially as described previously
(Koster et al., 2007). The following antibodies were used: Pg
(Cell Signaling, Boston, MA), b-catenin (Santa Cruz Biotechnology,
Santa Cruz, CA), Lef-1 (Millipore, Billerica, MA), and TCF-4
(Millipore). The following primers (Supplementary Table S1 online)
were used for quantitative real-time reverse transcriptase–-PCR: Dsc2-
4F/4R (Rel-binding site in Dsc2 promoter), DSC2-6F/6R (TCF/Lef-
binding site in Dsc2 promoter), and DSC3-3F/3R (TCF/Lef-binding site
in Dsc3 promoter). The data shown are based on three independent
experiments.
Generation of Dsc3-LacZ transgenic mice
The BAC vector RP23-290M4 (BACPAC Resource, Children’s Hospi-
tal Oakland Research Institute, Oakland, CA), which contains the
entire mouse Dsc3 gene, including 29 kb of 50 upstream and 90 kb of
30 downstream sequences, was used to generate the Dsc3-LacZ
transgene. A promoter-less LacZ cassette (NLS-LacZ-PA cassette;
provided by Dr Ming-Jer Tsai, Baylor College of Medicine, Houston,
TX) was inserted into exon 1 of the Dsc3 gene immediately
downstream of the start codon. The LacZ cassette contains a nuclear
localization sequence, i.e., transgenic mice can be identified by the
detection of b-galactosidase activity in nuclei.
Immunostaining, b-galactosidase staining, western blotting, and
Co-Immunoprecipitation
All experiments were conducted following standard protocols. The
following antibodies were used: Lef-1 (Cell Signaling), KT3 antibody
(Ansgar Schmidt, University of Marburg); normal IgG (Millipore),
Lamin B1 (Santa Cruz Biotechnology), a-tubulin (Sigma, Saint-Louis,
MO), DSC3 (Cheng et al., 2004), plakoglobin (Firtzgerald, North
Acton, MA), b-galactosidase (a gift from Dennis Roop, UC Denver);
horseradish peroxidase–conjugated and biotinylated secondary
antibodies (Vector Laboratories, Burlingame, CA); and Alexa
Fluor–coupled secondary antibodies (Invitrogen, Grand Island, NY).
Antibody binding was detected and quantified as described
previously (Koch et al., 2000).
Quantitative real-time quantitative reverse transcriptase–PCR
Real-time reverse transcriptase–PCR was performed using a
LightCycler 480 from Roche (Indianapolis, IN), following the manu-
facturer’s recommendations. Dsc2 and Dsc3 complementary DNAs
were amplified with ‘‘assay-on-demand probes’’ Mm00516355_m1
and Mm00492270_m1, respectively, from Applied Biosystems. A
glyceraldehyde-3-phosphate dehydrogenase probe set from Applied
Biosystems was used as an internal control. The data shown are based
on three independent experiments.
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